Peter García
Director of Finance/CFO chez ALX ONCOLOGY HOLDINGS INC.
Fortune : 1 M $ au 31/03/2024
Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Jaume Pons | M | 58 | 9 ans | |
| Dominique Monnet | M | 65 |
Noden Pharma USA, Inc.
 Noden Pharma USA, Inc. Electronic Equipment/InstrumentsElectronic Technology Noden Pharma USA, Inc. is engaged in manufacturing and commercialization of filled and finished medicine products. The company is headquartered in Orlando, FL. | 7 ans |
| James Brown | M | 67 | 26 ans | |
| Elizabeth O'Farrell | F | 59 | 6 ans | |
| Timothy Papp | M | 48 | 2 ans | |
| Gail Maderis | F | 66 | 3 ans | |
| Jian Li | F | 53 | 24 ans | |
| Jason Lettmann | M | 46 | 4 ans | |
| Jason Hartlove | M | - |
Nanosys, Inc.
 Nanosys, Inc. Chemicals: SpecialtyProcess Industries Nanosys, Inc. develops and manufactures inorganic nanostructures and other related products. It offers Ultra HD television. The company was founded by Paul A. Alivisatos, Stephen Empedocles, Peidong Yang, Robert M. Metcalfe, Jim Heath, Paul McEuen, Christoph H. Westphal, Moungi Bawendi, Lawrence A. Bock, Calvin Y. H. Chow, Chunming Niu, Karen Vergura, Hongkun Park, George Pontis and Charles M. Lieber in 2001 and is headquartered in Milpitas, CA. | 16 ans |
| Judith Robertson | F | 64 | 5 ans | |
| Gail Farfel | M | 60 | 5 ans | |
| Sophia Randolph | M | 56 | 8 ans | |
| Judy Joice | F | 67 | 17 ans | |
| David J. Ellis | M | - | 13 ans | |
| Terrence Blaschke | M | 81 | 18 ans | |
| Christopher Stone | M | 59 |
Noden Pharma USA, Inc.
Noden Pharma USA, Inc. Electronic Equipment/InstrumentsElectronic Technology Noden Pharma USA, Inc. is engaged in manufacturing and commercialization of filled and finished medicine products. The company is headquartered in Orlando, FL. | - |
| Rekha Hemrajani | F | 54 | 4 ans | |
| Corey Goodman | M | 72 | 9 ans | |
| Mohammad Azab | M | 68 | 3 ans | |
| Christy Horgan | F | - | 7 ans | |
| Hong I. Wan | M | - | 9 ans | |
| Hank Stern | M | - | 9 ans | |
| Shelly Pinto | F | 48 | 3 ans | |
| John Francis Cogan | M | 76 |
Stanford University
| 44 ans |
| Chris Byrd | M | - | 2 ans | |
| Keith L. Lui | M | - | 4 ans | |
| Dorothy Engelking | F | 63 | 2 ans | |
| Wei Qi Lin | M | - | 16 ans | |
| Krishna C. Saraswat | M | 77 |
Stanford University
| 41 ans |
| Michael Chang | M | - | 9 ans | |
| Norman Sussman | M | 71 | 4 ans | |
| Jeffrey Pfeffer | M | 77 |
Stanford University
| 45 ans |
| J. Garland | M | 55 | 2 ans | |
| Athanasios Tsiatis | M | - | 3 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Philip C. Ranker | M | 64 | 7 ans | |
| Mitchell Gold | M | 57 | 12 ans | |
| Kathryn Falberg | F | 63 |
University of California, Los Angeles
| 9 ans |
| Martin Simonetti | M | 66 | 14 ans | |
| Michael Arenberg | M | 54 | 23 ans | |
| James Karis | M | 76 |
MDRNA, Inc.
 MDRNA, Inc. Miscellaneous Commercial ServicesCommercial Services MDRNA, Inc. engages in development and commercialization of innovative products based on proprietary molecular biology-based intranasal drug delivery technology. The company creates or utilizes novel formulation components or excipients that can transiently manipulate or open 'tight junctions' between cells in various tissues and thereby allow therapeutic drugs to reach the blood stream. The company is located in Hauppauge, NY. | 3 ans |
| Natasha Hernday | F | 52 | 20 ans | |
| David Hoffmann | M | 79 | 21 ans | |
| Bruce R. York | M | 69 |
MDRNA, Inc.
MDRNA, Inc. Miscellaneous Commercial ServicesCommercial Services MDRNA, Inc. engages in development and commercialization of innovative products based on proprietary molecular biology-based intranasal drug delivery technology. The company creates or utilizes novel formulation components or excipients that can transiently manipulate or open 'tight junctions' between cells in various tissues and thereby allow therapeutic drugs to reach the blood stream. The company is located in Hauppauge, NY. | 6 ans |
| Edward A. Imbrogno | M | 60 | 3 ans | |
| Stephen Wurzburg | M | - |
Stanford University
| 8 ans |
| Marc M. P. de Garidel | M | 66 | 15 ans | |
| Gary Titus | M | 64 |
IntraBiotics Pharmaceuticals, Inc.
 IntraBiotics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology IntraBiotics, a developer of antibiotics and antifungals is focused on one drug candidate, iseganan hydrochloride oral solution, which would be used for the prevention of ventilator-associated pneumonia and to help cystic fibrosis patients fight respiratory infections.
Nuvelo, Inc.
| 6 ans |
| Christopher Henney | M | 83 | 12 ans | |
| Michael Taylor | M | 69 | 2 ans | |
| Ernest Mario | M | 85 |
IntraBiotics Pharmaceuticals, Inc.
IntraBiotics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology IntraBiotics, a developer of antibiotics and antifungals is focused on one drug candidate, iseganan hydrochloride oral solution, which would be used for the prevention of ventilator-associated pneumonia and to help cystic fibrosis patients fight respiratory infections. | 1 ans |
| Douglas G. Watson | M | 79 | 15 ans | |
| Kevin Sharer | M | 76 | 20 ans | |
| Grant E. Finlayson | M | - |
Stanford University
| 6 ans |
| James Rothman | M | 74 |
MDRNA, Inc.
MDRNA, Inc. Miscellaneous Commercial ServicesCommercial Services MDRNA, Inc. engages in development and commercialization of innovative products based on proprietary molecular biology-based intranasal drug delivery technology. The company creates or utilizes novel formulation components or excipients that can transiently manipulate or open 'tight junctions' between cells in various tissues and thereby allow therapeutic drugs to reach the blood stream. The company is located in Hauppauge, NY. | 2 ans |
| Jody Lindell | F | 72 | 9 ans | |
| Ernesto Cervera | M | 66 |
University of California, Los Angeles
| 2 ans |
| Patricia A. Turney | F | 57 | 23 ans | |
| Syed Zahoor Hassan | M | - |
Stanford University
| 5 ans |
| Chuck Stonecipher | M | - |
Stanford University
| 5 ans |
| J. B. Holston | M | - |
Stanford University
| 8 ans |
| Shlomo Yanai | M | 71 | 2 ans | |
| Keith Leonard | M | 62 |
University of California, Los Angeles
| 18 ans |
| Alan W. Marty | M | - |
Stanford University
| 2 ans |
| Mohammad Ali Hassan Mohammad Ikwan | M | - |
Stanford University
| 3 ans |
| Geoff S. Keith | M | - |
Stanford University
| 5 ans |
| Katherine Fleming Ashton | F | - |
Stanford University
| 8 ans |
| Stephen Fisher | M | 60 |
Stanford University
| 5 ans |
| Iain Lo | M | 62 |
University of California, Los Angeles
| 5 ans |
| Gdaliahoo Krieger | M | 75 |
Stanford University
| 4 ans |
| Andrew von Eschenbach | M | 82 | 3 ans | |
| Susan Lundeen Smuck | F | 57 | 12 ans | |
| John M. Cioffi | M | 66 |
Stanford University
| 5 ans |
| Julia Eastland | F | 59 | 8 ans | |
| Susan B. Bayh | F | 64 | 12 ans | |
| David Alan Ward | M | - |
Stanford University
| 8 ans |
| Simon Benito | M | 79 | 17 ans | |
| Barry A. Polisky | M | 78 |
MDRNA, Inc.
MDRNA, Inc. Miscellaneous Commercial ServicesCommercial Services MDRNA, Inc. engages in development and commercialization of innovative products based on proprietary molecular biology-based intranasal drug delivery technology. The company creates or utilizes novel formulation components or excipients that can transiently manipulate or open 'tight junctions' between cells in various tissues and thereby allow therapeutic drugs to reach the blood stream. The company is located in Hauppauge, NY. | 2 ans |
| Steven Ketchum | M | 59 |
IntraBiotics Pharmaceuticals, Inc.
IntraBiotics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology IntraBiotics, a developer of antibiotics and antifungals is focused on one drug candidate, iseganan hydrochloride oral solution, which would be used for the prevention of ventilator-associated pneumonia and to help cystic fibrosis patients fight respiratory infections. | 5 ans |
| Daniel L. Peters | M | 72 |
MDRNA, Inc.
MDRNA, Inc. Miscellaneous Commercial ServicesCommercial Services MDRNA, Inc. engages in development and commercialization of innovative products based on proprietary molecular biology-based intranasal drug delivery technology. The company creates or utilizes novel formulation components or excipients that can transiently manipulate or open 'tight junctions' between cells in various tissues and thereby allow therapeutic drugs to reach the blood stream. The company is located in Hauppauge, NY. | 2 ans |
| John A. Young | M | 91 |
Nanosys, Inc.
Nanosys, Inc. Chemicals: SpecialtyProcess Industries Nanosys, Inc. develops and manufactures inorganic nanostructures and other related products. It offers Ultra HD television. The company was founded by Paul A. Alivisatos, Stephen Empedocles, Peidong Yang, Robert M. Metcalfe, Jim Heath, Paul McEuen, Christoph H. Westphal, Moungi Bawendi, Lawrence A. Bock, Calvin Y. H. Chow, Chunming Niu, Karen Vergura, Hongkun Park, George Pontis and Charles M. Lieber in 2001 and is headquartered in Milpitas, CA. | - |
| Judith C. Pelham | F | 78 | 22 ans | |
| Bogdan Dziurzynski | M | 75 | 14 ans | |
| Samuel Saks | M | 69 | 4 ans | |
| Jon Saxe | M | 88 | 19 ans | |
| Elias Bendekgey | M | 66 |
Nuvelo, Inc.
| 5 ans |
| Larry Bock | M | 64 |
Nanosys, Inc.
Nanosys, Inc. Chemicals: SpecialtyProcess Industries Nanosys, Inc. develops and manufactures inorganic nanostructures and other related products. It offers Ultra HD television. The company was founded by Paul A. Alivisatos, Stephen Empedocles, Peidong Yang, Robert M. Metcalfe, Jim Heath, Paul McEuen, Christoph H. Westphal, Moungi Bawendi, Lawrence A. Bock, Calvin Y. H. Chow, Chunming Niu, Karen Vergura, Hongkun Park, George Pontis and Charles M. Lieber in 2001 and is headquartered in Milpitas, CA. | 5 ans |
| Jeff Stevens | M | - |
Stanford University
| 8 ans |
| Lowell E. Sears | M | 73 | 14 ans | |
| Glen Y. Sato | M | 65 |
University of California, Los Angeles
| 3 ans |
| Frank Valone | M | 74 | 8 ans | |
| David Gryska | M | 68 | 6 ans | |
| Jean-Lou Chameau | M | 71 |
Stanford University
| 4 ans |
| Bruce R. Thaw | M | 71 |
MDRNA, Inc.
MDRNA, Inc. Miscellaneous Commercial ServicesCommercial Services MDRNA, Inc. engages in development and commercialization of innovative products based on proprietary molecular biology-based intranasal drug delivery technology. The company creates or utilizes novel formulation components or excipients that can transiently manipulate or open 'tight junctions' between cells in various tissues and thereby allow therapeutic drugs to reach the blood stream. The company is located in Hauppauge, NY. | 26 ans |
| David Russell Albin | M | 65 |
Stanford University
| 7 ans |
| Steve J. Rosston | M | 64 |
Stanford University
| 3 ans |
| Jean-Michel Valette | M | 63 |
Stanford University
| 5 ans |
| Harry F. Hixson | M | 84 | 6 ans | |
| Stephen Farrell | M | 59 | 7 ans | |
| Gerardo Canet | M | 78 | 17 ans | |
| Yinyu Ye | M | 76 |
Stanford University
| 6 ans |
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Etats-Unis | 100 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Peter García
- Réseau Personnel
